Literature DB >> 22622037

Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis.

Yvonne Begus-Nahrmann1, Daniel Hartmann, Johann Kraus, Parisa Eshraghi, Annika Scheffold, Melanie Grieb, Volker Rasche, Peter Schirmacher, Han-Wong Lee, Hans A Kestler, André Lechel, K Lenhard Rudolph.   

Abstract

Telomere shortening limits the proliferative capacity of a cell, but perhaps surprisingly, shortening is also known to be associated with increased rates of tumor initiation. A current hypothesis suggests that telomere dysfunction increases tumor initiation by induction of chromosomal instability, but that initiated tumors need to reactivate telomerase for genome stabilization and tumor progression. This concept has not been tested in vivo, since appropriate mouse models were lacking. Here, we analyzed hepatocarcinogenesis in a mouse model of inducible telomere dysfunction on a telomerase-proficient background, in telomerase knockout mice with chronic telomere dysfunction (G3 mTerc-/-), and in WT mice with functional telomeres and telomerase. Transient or chronic telomere dysfunction enhanced the rates of chromosomal aberrations during hepatocarcinogenesis, but only telomerase-proficient mice exhibited significantly increased rates of macroscopic tumor formation in response to telomere dysfunction. In contrast, telomere dysfunction resulted in pronounced accumulation of DNA damage, cell-cycle arrest, and apoptosis in telomerase-deficient liver tumors. Together, these data provide in vivo evidence that transient telomere dysfunction during early or late stages of tumorigenesis promotes chromosomal instability and carcinogenesis in telomerase-proficient mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22622037      PMCID: PMC3366409          DOI: 10.1172/JCI61745

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Progenetix.net: an online repository for molecular cytogenetic aberration data.

Authors:  M Baudis; M L Cleary
Journal:  Bioinformatics       Date:  2001-12       Impact factor: 6.937

2.  Stringent doxycycline dependent control of CRE recombinase in vivo.

Authors:  Kai Schönig; Frieder Schwenk; Klaus Rajewsky; Hermann Bujard
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

3.  Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases.

Authors:  Zhihu Ding; Chang-Jiun Wu; Mariela Jaskelioff; Elena Ivanova; Maria Kost-Alimova; Alexei Protopopov; Gerald C Chu; Guocan Wang; Xin Lu; Emma S Labrot; Jian Hu; Wei Wang; Yonghong Xiao; Hailei Zhang; Jianhua Zhang; Jingfang Zhang; Boyi Gan; Samuel R Perry; Shan Jiang; Liren Li; James W Horner; Y Alan Wang; Lynda Chin; Ronald A DePinho
Journal:  Cell       Date:  2012-02-16       Impact factor: 41.582

4.  Telomere dysfunction and evolution of intestinal carcinoma in mice and humans.

Authors:  K L Rudolph; M Millard; M W Bosenberg; R A DePinho
Journal:  Nat Genet       Date:  2001-06       Impact factor: 38.330

5.  Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice.

Authors:  S E Artandi; S Chang; S L Lee; S Alson; G J Gottlieb; L Chin; R A DePinho
Journal:  Nature       Date:  2000-08-10       Impact factor: 49.962

Review 6.  Does the ribosome translate cancer?

Authors:  Davide Ruggero; Pier Paolo Pandolfi
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

7.  Different telomere damage signaling pathways in human and mouse cells.

Authors:  Agata Smogorzewska; Titia de Lange
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

Review 8.  Connecting chromosomes, crisis, and cancer.

Authors:  Richard S Maser; Ronald A DePinho
Journal:  Science       Date:  2002-07-26       Impact factor: 47.728

9.  Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma.

Authors:  Paraskevi A Farazi; Jonathan Glickman; Shan Jiang; Alice Yu; Karl Lenhard Rudolph; Ronald A DePinho
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

Review 10.  Telomeres and telomerase: a dual role in hepatocarcinogenesis.

Authors:  Ande Satyanarayana; Michael P Manns; K Lenhard Rudolph
Journal:  Hepatology       Date:  2004-08       Impact factor: 17.425

View more
  21 in total

1.  Telomere shortening produces an inflammatory environment that increases tumor incidence in zebrafish.

Authors:  Kirsten Lex; Mariana Maia Gil; Bruno Lopes-Bastos; Margarida Figueira; Marta Marzullo; Kety Giannetti; Tânia Carvalho; Miguel Godinho Ferreira
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-17       Impact factor: 11.205

2.  Telomere stability and carcinogenesis: an off-again, on-again relationship.

Authors:  Jennifer J Wanat; F Brad Johnson
Journal:  J Clin Invest       Date:  2012-05-24       Impact factor: 14.808

3.  Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients.

Authors:  Richard Ofner; Cathrin Ritter; Barbara Heidenreich; Rajiv Kumar; Selma Ugurel; David Schrama; Jürgen C Becker
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-18       Impact factor: 4.553

Review 4.  Biology of telomeres: importance in etiology of esophageal cancer and as therapeutic target.

Authors:  Jagannath Pal; Jason S Gold; Nikhil C Munshi; Masood A Shammas
Journal:  Transl Res       Date:  2013-10-01       Impact factor: 7.012

Review 5.  Telomerase at the intersection of cancer and aging.

Authors:  Bruno Bernardes de Jesus; Maria A Blasco
Journal:  Trends Genet       Date:  2013-07-19       Impact factor: 11.639

Review 6.  The role of telomeres and telomerase in cirrhosis and liver cancer.

Authors:  Jean-Charles Nault; Massih Ningarhari; Sandra Rebouissou; Jessica Zucman-Rossi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-06-28       Impact factor: 46.802

Review 7.  Telomeres: history, health, and hallmarks of aging.

Authors:  Deepavali Chakravarti; Kyle A LaBella; Ronald A DePinho
Journal:  Cell       Date:  2021-01-14       Impact factor: 41.582

Review 8.  Potential of telomerase activation in extending health span and longevity.

Authors:  Bruno Bernardes de Jesus; Maria A Blasco
Journal:  Curr Opin Cell Biol       Date:  2012-10-18       Impact factor: 8.382

9.  Sources of contradictions in the evaluation of population genetic consequences after the chernobyl disaster.

Authors:  V I Glazko; T T Glazko
Journal:  Acta Naturae       Date:  2013-01       Impact factor: 1.845

10.  Loss of telomere protection: consequences and opportunities.

Authors:  Jacqueline J L Jacobs
Journal:  Front Oncol       Date:  2013-04-15       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.